Clinical diagnostic significance of 14-3-3η protein, high-mobility group box-1, anti-cyclic citrullinated peptide antibodies, anti-mutated citrullinated vimentin antibodies and rheumatoid factor in rheumatoid arthritis. Issue 1 (2nd January 2020)
- Record Type:
- Journal Article
- Title:
- Clinical diagnostic significance of 14-3-3η protein, high-mobility group box-1, anti-cyclic citrullinated peptide antibodies, anti-mutated citrullinated vimentin antibodies and rheumatoid factor in rheumatoid arthritis. Issue 1 (2nd January 2020)
- Main Title:
- Clinical diagnostic significance of 14-3-3η protein, high-mobility group box-1, anti-cyclic citrullinated peptide antibodies, anti-mutated citrullinated vimentin antibodies and rheumatoid factor in rheumatoid arthritis
- Authors:
- Huang, J
Zeng, T
Zhang, X
Tian, Y
Wu, Y
Yu, J
Pei, Z
Liu, Y
Hu, T
Tan, L - Abstract:
- ABSTRACT: Introduction : Circulating markers of rheumatoid arthritis (RA) include the 14–3-3η protein, high-mobility group box-1 (HMGB1), anti-cyclic citrullinated peptide (anti-CCP) antibodies, anti-mutated citrullinated vimentin (anti-MCV) antibodies and rheumatoid factor (RF). We set out to determine which two markers in combination provided best discriminatory power for this disease. Methods : We recruited 108 RA patients, 102 non-RA patients (SLE, AS, Sjogren's syndrome, MCTD) and 90 healthy controls. Sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio, negative likelihood ratio and the Youden index of each analyte were calculated and binary logistic regression analysis and receiver operating characteristic (ROC) curve were performed to evaluate their diagnostic value for RA alone and in paired combination. Results : As expected, all markers were elevated in RA patients ( P < 0.05). Binary logistic regression analysis showed that 14–3-3η had the highest odds ratio (95% CI) at 2.4 (1.9–2.8). Anti-CCP and anti-MCV had the highest areas under the curves [AUC (95% CI)] at 0.85 (0.78–0.90) and 0.85 (0.78–0.91) respectively (both P < 0.001). In serial detection (one marker followed by another), no combination had a Youden index >0.6. In parallel analysis (both considered together) several combinations had a Youden index >0.7, of which the highest (0.78) was anti-CCP with anti-MCV, with a sensitivity of 93.3% andABSTRACT: Introduction : Circulating markers of rheumatoid arthritis (RA) include the 14–3-3η protein, high-mobility group box-1 (HMGB1), anti-cyclic citrullinated peptide (anti-CCP) antibodies, anti-mutated citrullinated vimentin (anti-MCV) antibodies and rheumatoid factor (RF). We set out to determine which two markers in combination provided best discriminatory power for this disease. Methods : We recruited 108 RA patients, 102 non-RA patients (SLE, AS, Sjogren's syndrome, MCTD) and 90 healthy controls. Sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio, negative likelihood ratio and the Youden index of each analyte were calculated and binary logistic regression analysis and receiver operating characteristic (ROC) curve were performed to evaluate their diagnostic value for RA alone and in paired combination. Results : As expected, all markers were elevated in RA patients ( P < 0.05). Binary logistic regression analysis showed that 14–3-3η had the highest odds ratio (95% CI) at 2.4 (1.9–2.8). Anti-CCP and anti-MCV had the highest areas under the curves [AUC (95% CI)] at 0.85 (0.78–0.90) and 0.85 (0.78–0.91) respectively (both P < 0.001). In serial detection (one marker followed by another), no combination had a Youden index >0.6. In parallel analysis (both considered together) several combinations had a Youden index >0.7, of which the highest (0.78) was anti-CCP with anti-MCV, with a sensitivity of 93.3% and specificity of 84.7%. Conclusions : Despite individual increases in serum 14–3-3η, HMGB1, anti-CCP, anti-MCV and RF, the combination of anti-CCP and anti-MCV might be of great help for diagnostic in RA, and so should be considered as routine tests for this disease. … (more)
- Is Part Of:
- British journal of biomedical science. Volume 77:Issue 1(2020)
- Journal:
- British journal of biomedical science
- Issue:
- Volume 77:Issue 1(2020)
- Issue Display:
- Volume 77, Issue 1 (2020)
- Year:
- 2020
- Volume:
- 77
- Issue:
- 1
- Issue Sort Value:
- 2020-0077-0001-0000
- Page Start:
- 19
- Page End:
- 23
- Publication Date:
- 2020-01-02
- Subjects:
- Rheumatoid arthritis -- 14-3-3η -- high-mobility group box-1 -- anti-cyclic citrullinated peptide antibodies -- anti-mutated citrullinated vimentin antibodies -- rheumatoid factor
Medical sciences -- Periodicals
Medical technology -- Periodicals
Biological Science Disciplines
Clinical Laboratory Techniques
Medical Laboratory Science
Anatomie pathologique
Medical sciences
Medical technology
Klinische chemie
Laboratoriumonderzoek
Periodicals
Periodicals
616.0756
610.07 M489L - Journal URLs:
- http://catalog.hathitrust.org/api/volumes/oclc/27845663.html ↗
http://www.ibms.org/index.cfm?method=publications.british_journal ↗
http://www.tandfonline.com/loi/tbbs20?open=67&repitition=0 ↗
https://www.frontierspartnerships.org/journals/british-journal-of-biomedical-science ↗ - DOI:
- 10.1080/09674845.2019.1658425 ↗
- Languages:
- English
- ISSNs:
- 0967-4845
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2306.730000
British Library HMNTS - ELD Digital store - Ingest File:
- 12674.xml